GLPG

#7023
Galapagos NV
33.6600
+1.29%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
33.6600
33.6600
Intervallo Annuale
29.8080
36.2200
Variazione giornaliera
+1.29%
Variazione Mensile
-2.77%
Variazione di 6 mesi
+4.86%
Variazione Annuale
+4.86%
Chiusura Precedente
33.2300
Open
33.6600
Bid
Ask
Low
33.6600
High
33.6600
Volume
18
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 704
  • Founded 1999
  • CEO Paul StoffelsPaul Stoffels
  • Website www.glpg.com
  • Headquarter Belgium
  • FIGI BBG000BJQY75
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Galapagos NV - American Depositary Shares

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.

Notizie